Premier Alternatives

Embolx

Sunnyvale, CA · Founded 2013 · Privately Held (backing)

Developer of medical devices designed for arterial embolization procedures. Embolx is based in Sunnyvale, CA and was founded in 2013. Its last reported valuation was $37.6 million in Jul 2021. It has raised $16.5 million across 3 recorded rounds; the latest was a $1.6 million seed round in Oct 2022.

Last reported valuation
$37.6M
Oct 2026
Priced at
—
Total raised
$16.5M
Last round
Seed Round
Oct 2022

Embolx key facts

as of Oct 2026
  • Developer of medical devices designed for arterial embolization procedures.
  • Embolx is valued at approximately $37.6M as of Oct 2026 (last reported valuation).
  • It has raised $16.5M across 3 recorded rounds; the latest was Seed Round ($1.6M) in Oct 2022.
  • Notable investors include US National Science Foundation, MedTech Innovator, Keiretsu Forum, Band of Angels, VI Ventures — 14 tracked in total.
  • Embolx has filed 5 Form Ds with the SEC since 2014, most recently Nov 2022 ($1.6M sold to 5 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$37.6M

Embolx's last reported valuation, Jul 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Embolx with a free account
  • ·The complete investor list: 14 names
  • ·Watch Embolx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Embolx funding rounds

3 rounds
Oct 2022Seed Round$1.6MSEC filing▮
May 2014Seed Round$250KSEC filing▮
Feb 2014Seed Round$250KSEC filing▮
Full funding history →

Embolx valuation

Embolx's last reported valuation was $37.6 million in Jul 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Embolx raised?

Embolx has raised $16.5 million in total; 3 of its rounds are on record, from 2014 on. The largest on record was a $250,000 seed round in Feb 2014; the most recent was a $1.6 million seed round in Oct 2022.

Embolx has filed 5 Form Ds with the SEC since 2014, most recently in Nov 2022 ($1.6 million sold to 5 investors).

Embolx investors

14 investors are on record for Embolx, including US National Science Foundation, MedTech Innovator, Keiretsu Forum and Band of Angels. The seed round in Oct 2022 drew 5 investors.

About Embolx

Developer of medical devices designed for arterial embolization procedures. The company offers advanced microcatheters that leverage both high- and low-pressure technologies, enabling interventional radiologists and healthcare providers to perform targeted embolization with enhanced efficiency, ease of use, and extended shelf life, thereby supporting improved patient outcomes in the medical device market.

Sector
Healthcare
HQ
Sunnyvale, CA, United States
Founded
2013
Employees
16
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.